Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-055844

Chief Executive Officer sold 6,000 shares at $66.76 ($400,560)

  • Chief Executive Officer acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Chief Executive Officer 2017-10-02 Option exercise +6,000 $0.30 $1,815 6,000 D
Schenkein David P Chief Executive Officer 2017-10-02 Sale −6,000 $66.76 $400,560 0 D
Derivatives
Schenkein David P Chief Executive Officer 2017-10-02 Option exercise · Stock option (right to buy) −6,000 112,656 D
Open-market sales · 6,000 sh · avg $66.76 · $400,560
Loading xslF345X03/doc4.xml…